MedPath

Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage

Conditions
Hypertension
Diabetes
Anesthesia
Registration Number
NCT02864212
Lead Sponsor
Coordinación de Investigación en Salud, Mexico
Brief Summary

The aim of this observational study is to create a data base to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system.

Detailed Description

The aim of this observational study is to create a database to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system.

The observed drugs in this study are fast acting insulin, propofol and sodium nitroprusside.

The effect of insulin will be measured by a continuous glucose monitor, the effect of propofol by a bispectral index monitor and the the effect of sodium nitroprusside by a invasive blood pressure monitor.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • American Society of Anesthesiologists (ASA) physical status I, II, II
Exclusion Criteria
  • Impossibility to measure depth of anesthesia or invasive blood pressure. Impossibility of using glucose monitor.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
GlucoseEvery 5 minutes during 3 days.

The glucose will be measured by a continuous glucose monitor. For the group of patients for diabetes.

Note: This protocol has three primary outputs because its objective is to create a database of each output to analyze the response to the associated drug (insulin, propofol and sodium nitroprusside.

Bispectral IndexEvery second during surgery

Depth of anesthesia will be measured by a Bispectral Index monitor.

Invasive blood pressureEvery 5 minutes during surgery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Unidad de Investigación Médica en Enfermedades Metabólicas IMSS

🇲🇽

Mexico, Mexico City, Mexico

© Copyright 2025. All Rights Reserved by MedPath